RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs Blue Guardian Futures

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

BGFT

Blue Guardian Futures

DNA FUNDED

METRIC

BLUE GUARDIAN FUTURES

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

100%

—

MAX FUNDING

$450,000

—

MIN COST

$84

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

BLUE GUARDIAN FUTURES DETAILS

STEPS: 1-phase
DRAWDOWN: Trailing EOD
MARKETS: Futures
PLATFORMS: MT5, Matchtrader, Tradelocker, Tradovate, ProjectX, Volsys, Deepcharts

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

Blue Guardian Futures PROS

+Profit split of 100% is the maximum possible, far exceeding the industry average of 84.7%
+Min challenge cost of $84 is well below the industry average of $186.70, reducing entry costs
+Steps to funded is 1, well below the industry average of 1.6, offering a streamlined path to capital
+Days to first payout is 5, slightly faster than the industry average of 6.5 days

Blue Guardian Futures CONS

−Overall drawdown of 3.5% is expressed as a percentage but is exceptionally tight, increasing disqualification risk
−Max funding of $450,000 is below the industry average of $839,272, limiting maximum earning potential
−Futures-only market access restricts traders who prefer Forex, Indices, or other asset classes

PROPDNA VERDICT

DNA Funded

Higher trust score (0/100). Slower payouts at —d.

START WITH DNAF